Accès ouvert
2019
article
OpenAlex
Shinya Goto, Pantep Angchaisuksiri, Jean‐Pierre Bassand, A. John Camm et autres
Background Using data from the GARFIELD ‐ AF (Global Anticoagulant Registry in the FIELD –Atrial Fibrillation), we evaluated the impact of chronic kidney disease ( CKD ) stage on clinical outcomes in patients with newly diagnosed atrial fibrillation ( AF ). Methods …
jp, th, fr, gb, dk, au, us, cn, de, sg, kr, in, ca, nl
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne, Rajashekhar Durgaprasad et autres
BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes …
in, pk, gb, us
(code pays fourni par la source)
1996
other
OpenAlex
Jerónimo Farré, F Navarro, J Romero, D Rivas et autres
The known risk of embolic events in patients with recurrent or chronic atrial fibrillation makes it mandatory to recommend oral anticoagulation in patients with rheumatic mitral valve disease, specially mitral stenosis to maintain an INR between 2.0 and 3.0. If despite this …
es
(code pays fourni par la source)